Summary & Key Points
"Through the DITRAME and DITRAME+ trials, the PAC-CI Program has helped advance strategies to reduce mother-to-child transmission of HIV. This work has made it possible to better tailor care across several dimensions"
Did you know?
Through DITRAME and DITRAME+, PAC-CI has helped advance efforts to prevent mother-to-child transmission of HIV.
Through the DITRAME and DITRAME+ trials, the PAC-CI Program has helped advance strategies to reduce mother-to-child transmission of HIV.
This work has helped better guide care around several key areas, including treatment for the mother, protection of the child, and practices related to pregnancy, childbirth, and breastfeeding.
By helping to generate useful knowledge on this issue, PAC-CI has contributed to improving prevention approaches in a field where every advance can bring about lasting change in the life course of a mother and her child.
The DITRAME and DITRAME+ trials thus illustrate the Program’s commitment to the most vulnerable populations, as well as its ability to conduct research with a significant impact on public health.
Christian KOUADIO
Clinical Research Associate and Communications Manager at PAC-CI
Contact the author
